問卷

TPIDB > Search Result

Search Result

篩選

List

3348Cases

2022-06-15 - 2029-09-30

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2015-10-01 - 2024-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2014-01-01 - 2021-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2016-08-01 - 2018-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2022-02-04 - 2025-06-13

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2021-10-01 - 2027-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2013-10-01 - 2025-04-01

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2024-07-17 - 2027-07-30

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2019-04-01 - 2023-12-07

Phase I/II

Completed
A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer
  • Condition/Disease

    Non-Small Cell Lung Cancer

  • Test Drug

    TAK-788 (AP32788)

Participate Sites
6Sites

Terminated6Sites

2024-03-01 - 2027-05-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites